Enzymatica Publ Financials
| ENZY Stock | SEK 1.74 0.07 4.19% |
Enzymatica |
Understanding current and past Enzymatica Publ Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Enzymatica Publ's financial statements are interrelated, with each one affecting the others. For example, an increase in Enzymatica Publ's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Enzymatica Publ's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Enzymatica publ AB. Check Enzymatica Publ's Beneish M Score to see the likelihood of Enzymatica Publ's management manipulating its earnings.
Enzymatica Publ Stock Summary
Enzymatica Publ competes with Oncopeptides, Diamyd Medical, Kancera AB, Bonesupport Holding, and Cantargia. Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden. Enzymatica operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 24 people.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0003943620 |
| Business Address | Ideon Science Park, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.enzymatica.se |
| Phone | 46 4 62 86 31 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Enzymatica Publ without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Enzymatica Stock, because this is throwing your money away. Analyzing the key information contained in Enzymatica Publ's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Enzymatica Publ Key Financial Ratios
Enzymatica Publ's financial ratios allow both analysts and investors to convert raw data from Enzymatica Publ's financial statements into concise, actionable information that can be used to evaluate the performance of Enzymatica Publ over time and compare it to other companies across industries.Enzymatica Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Enzymatica Publ's current stock value. Our valuation model uses many indicators to compare Enzymatica Publ value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enzymatica Publ competition to find correlations between indicators driving Enzymatica Publ's intrinsic value. More Info.Enzymatica publ AB is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enzymatica Publ's earnings, one of the primary drivers of an investment's value.Enzymatica publ AB Systematic Risk
Enzymatica Publ's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Enzymatica Publ volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Enzymatica publ AB correlated with the market. If Beta is less than 0 Enzymatica Publ generally moves in the opposite direction as compared to the market. If Enzymatica Publ Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Enzymatica publ AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Enzymatica Publ is generally in the same direction as the market. If Beta > 1 Enzymatica Publ moves generally in the same direction as, but more than the movement of the benchmark.
Enzymatica Publ December 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Enzymatica Publ help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Enzymatica publ AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Enzymatica publ AB based on widely used predictive technical indicators. In general, we focus on analyzing Enzymatica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Enzymatica Publ's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 20.17 | |||
| Value At Risk | (4.50) | |||
| Potential Upside | 4.4 |
Additional Tools for Enzymatica Stock Analysis
When running Enzymatica Publ's price analysis, check to measure Enzymatica Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzymatica Publ is operating at the current time. Most of Enzymatica Publ's value examination focuses on studying past and present price action to predict the probability of Enzymatica Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzymatica Publ's price. Additionally, you may evaluate how the addition of Enzymatica Publ to your portfolios can decrease your overall portfolio volatility.